Hybridoma clones and monoclonal antibodies to CD9
US9862773B2 · kind B2 · utility
0Cited by
1References
19Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 17, 2014 |
| Grant date | Jan 9, 2018 |
| Priority date | — |
| Expiry date | Sep 4, 2034 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/5308
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention is directed to a monoclonal antibody that recognizes human CD9 in its native form. The invention is also directed to a hybridoma cell line that produces the monoclonal antibody, and exosome isolation kits using the antibody.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.